Published in Ann Rheum Dis on January 01, 1968
Gout and hyperlipidaemia. Ann Rheum Dis (1974) 1.37
Proceedings: Gout, hypertriglyceridaemia, and alcohol consumption. Ann Rheum Dis (1974) 0.75
CLINICAL STUDIES OF THE BLOOD VOLUME. II. THE RELATION OF PLASMA AND TOTAL BLOOD VOLUME TO VENOUS PRESSURE, BLOOD VELOCITY RATE, PHYSICAL MEASUREMENTS, AGE AND SEX IN NINETY NORMAL HUMANS. J Clin Invest (1937) 47.11
The renal excretion of uric acid in patients with gout and in nongouty subjects. J Clin Invest (1959) 2.29
Effects of intrahepatic and extrahepatic infection on liver function. Br Med J (1966) 1.98
THE EFFECT OF SPONTANEOUS AND ARTIFICIALLY INDUCED FEVER ON LIVER FUNCTION. J Clin Invest (1948) 1.94
Allopurinol in treatment of gout. Br Med J (1966) 1.91
Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med (1961) 1.75
Determination of sulfobromophthalein in serum. Clin Chem (1957) 1.64
Liver function tests in chronic congestive heart failure. Circulation (1950) 1.35
The liver in obesity. AMA Arch Intern Med (1952) 1.14
An evaluation of factors influencing the discriminative effectiveness of a group of liver function tests. II. Normal limits of eleven representative hepatic tests. Gastroenterology (1955) 1.06
STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. II. THE EFFECT OF ARTIFICIALLY INDUCED FEVER, NORETHANDROLONE (NILEVAR), AND IOPANOIC ACID (TELAPAQUE). J Clin Invest (1964) 0.91
Liver morphology and function tests in obesity and during total starvation. Am J Dig Dis (1967) 0.88
Studies on bromsulfalein excretion. III. The simultaneous performance of the bromsulfalein and rose bengal excretion tests in individuals with normal hepatic function. Gastroenterology (1953) 0.85
Hepatic abnormalities in alcoholics with delirium tremens. Q J Stud Alcohol (1953) 0.79
Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report. Ann Rheum Dis (1974) 3.77
Physical activity, cystic erosions, and osteoporosis in rheumatoid arthritis. Ann Rheum Dis (1965) 3.62
Synovial cysts and rupture of the knee joint in rheumatoid arthritis. An arthrographic study. Ann Rheum Dis (1966) 3.09
Clinical survey of 354 patients with gout. Ann Rheum Dis (1970) 2.99
Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Rheumatology (Oxford) (2005) 2.28
Measurement of DNA antibodies by double antibody precipitation. Ann Rheum Dis (1973) 2.21
The clinical features and HLA associations of reactive arthritis associated with non-gonococcal urethritis. Q J Med (1979) 2.07
Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. Br Med J (1978) 2.01
Suprascapular nerve block for chronic shoulder pain in rheumatoid arthritis. BMJ (1989) 1.98
Influence of trauma on the development of chronic inflammatory polyarthritis. Ann Rheum Dis (1967) 1.93
Cytogenetic and scanning study of patients receiving intra-articular injections of gold-198 and yttrium-90. Ann Rheum Dis (1973) 1.93
Six cases of gamma-D myelomatosis. Lancet (1966) 1.92
Allopurinol in treatment of gout. Br Med J (1966) 1.91
An evaluated programme of rheumatology training for general practitioners. Br J Rheumatol (1986) 1.88
Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J (1973) 1.88
Blood and urine gold levels during chrysotherapy for rheumatoid arthritis. Rheumatol Rehabil (1975) 1.79
Controlled comparison of short-wave diathermy treatment with osteopathic treatment in non-specific low back pain. Lancet (1985) 1.74
Joint hypermobility--clinical aspects. Proc R Soc Med (1971) 1.70
Joint hypermobility--asset or liability? A study of joint mobility in ballet dancers. Ann Rheum Dis (1972) 1.67
Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis (1975) 1.67
Outpatient lumbar epidural corticosteroid injection in the management of sciatica. Br J Rheumatol (1988) 1.67
Single daily dose of allopurinol. Ann Rheum Dis (1975) 1.66
The influence of ageing on the in vivo elasticity of human skin. Gerontologia (1969) 1.65
Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis (1980) 1.65
Extradural corticosteroid injection in management of lumbar nerve root compression. Br Med J (1973) 1.56
Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health (2004) 1.48
Controlled inpatient study of tienilic acid in treatment of gout and hypertension. Ann Rheum Dis (1980) 1.46
Lower urinary tract symptoms in women with benign joint hypermobility syndrome: a case-control study. Int Urogynecol J (2013) 1.44
Radioactive colloidal gold. In chronic knee effusions with Baker's cyst formation. Ann Rheum Dis (1970) 1.41
A clinical and echocardiographic study of patients with the hypermobility syndrome. Ann Rheum Dis (1981) 1.39
Uric acid excretion in the relatives of patients with gout. Ann Rheum Dis (1970) 1.37
Elucidation of new structures in lignins of CAD- and COMT-deficient plants by NMR. Phytochemistry (2001) 1.37
Gout and hyperlipidaemia. Ann Rheum Dis (1974) 1.37
Physical properties of the skin in the Ehlers-Danlos syndrome. Ann Rheum Dis (1969) 1.36
Microscopic studies on skeletal muscle in gout patients treated with allopurinol. Q J Med (1971) 1.34
Probenecid, nephrotic syndrome, and renal failure. Ann Rheum Dis (1968) 1.30
A method for measuring human skin elasticity in vivo with observations of the effects of age, sex and pregnancy. Clin Sci (1970) 1.26
A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man. Clin Sci (1968) 1.25
Tissue gold levels after chrysotherapy. Ann Rheum Dis (1974) 1.25
Effect of weight-loss on plasma and urinary levels of uric acid. Lancet (1972) 1.25
Chronic monarticular synovitis. Diagnostic and prognostic features. Ann Rheum Dis (1975) 1.23
Plasma lipid levels in gout. Ann Rheum Dis (1972) 1.23
Crystal deposition in hyperparathyroidism. Ann Rheum Dis (1971) 1.22
Isolation of rubella virus from synovial fluid in five cases of seronegative arthritis. Lancet (1981) 1.18
Withdrawal of allopurinol in patients with gout. Ann Rheum Dis (1974) 1.17
Survey of joint mobility and in vivo skin elasticity in London schoolchildren. Ann Rheum Dis (1975) 1.16
Mitral valve prolapse and joint hypermobility: evidence for a systemic connective tissue abnormality? Ann Rheum Dis (1982) 1.14
Studies on neutrophil function. 1. Physiological and pharmacological aspects. Br J Haematol (1966) 1.13
Long-term management of gout and hyperuricaemia. Br Med J (1980) 1.13
Serum uric acid in England and Scotland. Ann Rheum Dis (1977) 1.10
Amiloride hydrochloride in hypertensive patients. Br Med J (1968) 1.09
Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? Neurogastroenterol Motil (2009) 1.07
Rheumatoid lung disease, pneumothorax, and eosinophilia. Ann Rheum Dis (1982) 1.06
Elasticity of human skin in vivo. A study of the physical properties of the skin in rheumatoid arthritis and the effect of corticosteroids. Ann Phys Med (1969) 1.06
Cardiac valvular disease in chronic inflammatory disorders of connective tissue. Factors influencing survival after surgery. Ann Rheum Dis (1975) 1.04
Fatal marrow aplasia in patient on penicillamine. Lancet (1976) 1.04
Chronic arthritis associated with the presence of intrasynovial rubella virus. Ann Rheum Dis (1983) 1.04
The genetic basis of the joint hypermobility syndromes. Rheumatology (Oxford) (2006) 1.03
Proceedings: Complement activation in Reiter's syndrome. Ann Rheum Dis (1975) 1.03
Studies of uric acid pool size and turnover rate. Ann Rheum Dis (1969) 1.03
Comparison of aspirin and benorylate in the treatment of rheumatoid arthritis. Br Med J (1972) 1.02
Clotrimazole in rheumatoid arthritis. Ann Rheum Dis (1980) 1.02
Recurrent blanching of the tongue due to giant cell arteritis. Ann Intern Med (1968) 1.00
Orudis in management of rheumatoid arthritis and osteoarthrosis of the hip: comparison with indomethacin. Br Med J (1972) 1.00
Extra-articular features of benign joint hypermobility syndrome. Br J Rheumatol (1996) 0.99
Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis. Br Med J (1974) 0.99
Factors inhibiting the excretion of uric acid. Proc R Soc Med (1966) 0.99
Drug-induced gout. Baillieres Clin Rheumatol (1991) 0.99
Subclass distribution of IgG and IgA responses to rubella virus in man. J Med Microbiol (1986) 0.99
A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract (2003) 0.99
Frequency of chondrocalcinosis of the knees and avascular necrosis of the femoral heads in gout: a controlled study. Ann Rheum Dis (1980) 0.98
Ruptured abdominal aorta infected with Salmonella brandenburg. Br Med J (1968) 0.98
Assessment of bone in Ehlers Danlos syndrome by ultrasound and densitometry. Ann Rheum Dis (1998) 0.98
Evidence that D-penicillamine alters the course of rheumatoid arthritis. Rheumatol Rehabil (1976) 0.97
Letter: "Ankylosing rheumatoid arthritis", ankylosing spondylitis, and HL-A antigens. Lancet (1974) 0.97
Devils's claw (Harpagophytum procumbens): pharmacological and clinical studies. Ann Rheum Dis (1981) 0.97
A double-blind cross-over trail of Prenazone and aspirin in the management of rheumatoid arthritis. Rheumatol Rehabil (1975) 0.97
The physical properties of skin in cutis laxa. Br J Dermatol (1971) 0.97
Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment. Ann Rheum Dis (1970) 0.96
Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol (1993) 0.96
Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction? Rheumatology (Oxford) (2004) 0.95
Career structure in rheumatology. Ann Rheum Dis (1969) 0.95
The stimulation of protein synthesis in human fibroblasts by therapeutic ultrasound. Rheumatol Rehabil (1975) 0.95
Uric acid clearance in patients with gout and normal subjects. Ann Rheum Dis (1971) 0.95
Chondrocalcinosis after parathyroidectomy. Ann Rheum Dis (1976) 0.95
Joint hypermobility and rectal evacuatory dysfunction: an etiological link in abnormal connective tissue? Neurogastroenterol Motil (2010) 0.95
Nonarticular gout: hyperuricemia and tophus formation without gouty arthritis. Arthritis Rheum (1983) 0.94
Multicentre trial of naproxen and phenylbutazone in acute gout. Ann Rheum Dis (1977) 0.94
Gastrointestinal blood loss and piroxicam. Lancet (1982) 0.93
Circulating levels of biologically active parathyroid hormone in rheumatic diseases. Ann Rheum Dis (1982) 0.93
Sulindac in osteoarthrosis of the hip. Rheumatol Rehabil (1976) 0.93
Family study of lipid and purine levels in gout patients. Ann Rheum Dis (1982) 0.93
Clinical and radiological features of osteonecrosis in systemic lupus erythematosus. Ann Rheum Dis (1979) 0.91
A review of stream nutrient criteria development in the United States. J Environ Qual (2013) 0.90
Double-blind trial of feprazone and phenylbutazone in acute gout. Curr Med Res Opin (1980) 0.90
Rubella and juvenile chronic arthritis. Arch Dis Child (1981) 0.90
Rheumatoid synovitis and joint disease. Relationship between arthroscopic and histological changes. Ann Rheum Dis (1975) 0.90